Fundraising Fox

OneVentures β€” 2021 Investments

5 investments dated 2021 Β· listed companies and verified rows first Β· show all

Coassemblecoassemble.comin𝕏Feb 2021 Β· $1.5M

Coassemble provides embedded training and learning infrastructure that integrates into existing workplace tools like intranets, products, and Slack.

AI & Machine LearningEdTechEnterprise SoftwareHR TechSaaSSales Tech

Ryan Macphersonin

Co-investorsClinton Capital PartnersEVP

Flippaflippa.comin𝕏Sep 2021

LaurenAI is an AI-powered tool that identifies off-market digital businesses matching a buyer's criteria and facilitates outreach to founders at scale.

AI & Machine LearningB2B MarketplacesE-commerceMarketplacesSaaSMelbourne, AU

Blake Hutchisonin

Lumarylumary.com𝕏Mar 2021 Β· $17M

Lumary develops ABA practice management software for autism therapy providers in the US and disability, aged care, and allied health providers in Australia, helping them manage operations and outcome-based care delivery.

Digital HealthHealthtechSaaSAdelaide, AU

Co-investorsArtesianSouth Australian Venture Capital Fund

Phocas Softwarephocassoftware.cominJan 2021

Phocas is a SaaS platform providing business intelligence and financial planning & analysis tools designed for wholesale distribution, manufacturing, and retail businesses.

Data & InfrastructureEnterprise SoftwareFintechSaaS

Myles Glashier(CEO and co-founder)inDamien O'Dea(Chief Product and Technology Officer)in

Co-investorsAccel-KKREllerston Capital

Other

Tracked investments with no reachable website or further public details β€” typically companies that wound down, renamed, or were absorbed.

Axial Biotherapeutics

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.